{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:36:22Z","timestamp":1762144582666},"reference-count":37,"publisher":"Japanese Pharmacological Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1254\/jphs.fp0071567","type":"journal-article","created":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T05:51:12Z","timestamp":1201067472000},"page":"46-55","source":"Crossref","is-referenced-by-count":10,"title":["Human Umbilical Cord Blood\u2013Derived CD34+ Cells Can Be Used as a Prophylactic Agent for Experimental Heatstroke"],"prefix":"10.1254","volume":"106","author":[{"given":"Wei-Shou","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiu-Kang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Tsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Chen J, Sankerg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682–2688.","DOI":"10.1161\/hs1101.098367"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003;73:296–307.","DOI":"10.1002\/jnr.10659"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J, et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 2002;11:275–281.","DOI":"10.3727\/096020198389924"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Saporta S, Kim JJ, Willing AE, Fu ES, Davis CD, Sanberg PR. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res. 2003;12:271–278.","DOI":"10.1089\/152581603322023007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chen SH, Chang FM, Tsai YC, Huang KF, Lin MT. Infusion of human umbilical cord blood cells protect against cerebral ischemia and damage during heatstroke in the rat. Exp Neurol. 2006;199:67–76.","DOI":"10.1016\/j.expneurol.2005.11.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bender JG, Unversagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991;77:2591–2596.","DOI":"10.1182\/blood.V77.12.2591.bloodjournal77122591"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Wu AG, Michejda M, Mazumder A, Meehan KR, Menender FA, Tchao JG, et al. Analysis and characterization of hematopietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood, and cord blood. Pediatr Res. 1999;46:163–169.","DOI":"10.1203\/00006450-199908000-00006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hsu SF, Niu KC, Lin CL, Lin MT. Brain cooling causes attenuation of cerebral oxidative stress, systemic inflammation, activated coagulation, and tissue ischemia\/injury during heatstroke. Shock. 2006;26:210–220.","DOI":"10.1097\/01.shk.0000223124.49265.10"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Chen SH, Chang FM, Chang HK, Chen WC, Huang KF, Lin MT. Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke. Shock. 2007;27:663–671.","DOI":"10.1097\/01.shk.0000248593.71388.40"},{"key":"10","unstructured":"10 Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press. New York, 1982."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chou YT, Lai ST, Lee CC, Lin MT. Hypothermia attenuates circulatory shock and cerebral ischemia in experimental heat stroke. Shock. 2003;19:388–393.","DOI":"10.1097\/00024382-200304000-00016"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Chen SH, Chang FM, Tsai YC, Huang KS, Lin MT. Resuscitation from experimental heatstroke by transplantation of human umbilical cord blood cells. Crit Care Med. 2005;33:1377–1383.","DOI":"10.1097\/01.CCM.0000165966.28936.89"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Berg DT, Gerlitz B, Shang J, Smith T, Santa P, Richardson MA, et al. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci U S A. 2003;100:4423–4428.","DOI":"10.1073\/pnas.0736918100"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pulsinelli WA, Levy DE, Duffy TE. Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann Neurol. 1982;11:499–509.","DOI":"10.1002\/ana.410110510"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Lee JJ, Liu MT, Wang NL, Lin CL, Chang CK. Platonin, a cyanine photosensitizing dye, causes attenuation of circulatory shock, hypercoagulable state, and tissue ischemia during heatstroke. Shock. 2005;24:577–582.","DOI":"10.1097\/01.shk.0000184284.49752.38"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B. Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A. 2003;100:1364–1369.","DOI":"10.1073\/pnas.0336479100"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci U S A. 2003;100:2088–2093.","DOI":"10.1073\/pnas.0337659100"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 2000;290:1775–1779.","DOI":"10.1126\/science.290.5497.1775"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004;35:2385–2389.","DOI":"10.1161\/01.STR.0000141680.49960.d7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 1995;373:339–341.","DOI":"10.1038\/373339a0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Shingo T, Date I, Yoshida H, Ohmoto T. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson’s disease. J Neurosci Res. 2002;69:946–954.","DOI":"10.1002\/jnr.10375"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Shingo T, Date I, Yoshida H, Ohmoto T. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson’s disease. J Neurosci Res. 2002;69:946–954.","DOI":"10.1002\/jnr.10375"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Zhang WR, Hayashi T, Iwai M, Nagano I, Sato K, Manabe Y, et al. Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat. Brain Res. 2001;903:253–256.","DOI":"10.1016\/S0006-8993(01)02364-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Zhang WR, Sato K, Iwa M, Nagano I, Manabe Y, Abe K. Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. Brain Res. 2002;947:140–145.","DOI":"10.1016\/S0006-8993(02)02923-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther. 2005;11:96–104.","DOI":"10.1016\/j.ymthe.2004.09.020"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Shapiro Y, Alkan M, Epstein Y, Newman F, Magazanik A. Increase in rat intestinal permeability to endotoxin during hyperthermia. Eup J Appl Physiol Occup Physiol. 1986;55:410–412.","DOI":"10.1007\/BF00422742"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Sharma HS, Westman J, Alm P, Sjoquist PO, Cervos-Navarro J, Nyberg F. Involvement of nitric oxide in the pathophysiology of acute heat stress in the rat. Influence of a new antioxidant compound H-290\/51. Ann N Y Acad Sci. 1997;813:581–590.","DOI":"10.1111\/j.1749-6632.1997.tb51749.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Hsiao SH, Chang CP, Chiu TH, Lin MT. Resuscitation from experimental heatstroke by brain cooling therapy. Resuscitation. 2007;73:437–445.","DOI":"10.1016\/j.resuscitation.2006.11.003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Hall DM, Buettner GR, Oberley LW, Xu L, Matthes RD, Gisolfi CV. Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circul Physiol. 2001;280:H509–H521.","DOI":"10.1152\/ajpheart.2001.280.2.H509"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Chang CP, Lee CC, Chen SH, Lin MT. Aminoguanidine protects against intracranial hypertension and cerebral ischemic injury in experimental heatstroke. J Pharmacol Sci. 2004;95:56–64.","DOI":"10.1254\/jphs.95.56"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001;21:2–14.","DOI":"10.1097\/00004647-200101000-00002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Nakagawa Y, Homma S, Yamamoto I, Banno M, Nakazato H, Imanaga H, et al. In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin. Cancer Immunol Immunother. 1993;37:157–162.","DOI":"10.1007\/BF01525429"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Schirmer WJ, Schirmer JM, Fry DE. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg. 1989;124:445–448.","DOI":"10.1001\/archsurg.1989.01410040055012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling-regulation of the immune response in normal and critically ill state. Crit Care Med. 2000;28:N3–N12.","DOI":"10.1097\/00003246-200004001-00002"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Dematte JE, O’Mara K, Buescher J, Whitney CG, Forsythe S, McNamee T, et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med. 1998;129:173–181.","DOI":"10.7326\/0003-4819-129-3-199808010-00001"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Bouchama A, Cafege A, Devol EB, Labdi O, el Assil K, Seraj M. Ineffectiveness of dantrolene sodium in the treatment of heatstroke. Crit Care Med. 1991;19:176–180.","DOI":"10.1097\/00003246-199102000-00011"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Chang CK, Chang CP, Chiu WT, Lin MT. Prevention and repair of circulatory shock and cerebral ischemia\/injury by various agents in experimental heatstroke. Curr Med Chem. 2006;13:3145–3154.","DOI":"10.2174\/092986706778742945"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:16:39Z","timestamp":1621437399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/106\/1\/106_FP0071567\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.fp0071567","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}